MIPSpro Enterprise QCDR measures
Quality Id | Measure Name | High Priority | Measure Type | |
---|---|---|---|---|
ACRAD15 | Report Turnaround Time: Radiography | Process | Details | |
ACRAD16 | Report Turnaround Time: Ultrasound (Excluding Breast US) | Process | Details | |
ACRAD17 | Report Turnaround Time: MRI | Process | Details | |
ACRAD18 | Report Turnaround Time: CT | Process | Details | |
ACRAD19 | Report Turnaround Time: PET | Process | Details | |
ACRAD25 | Report Turnaround Time: Mammography | Outcome | Details | |
ACRAD36 | Incidental Coronary Artery Calcification Reported on Chest CT | Outcome | Details | |
ACRAD37 | Interpretation of CT Pulmonary Angiography (CTPA) for Pulmonary Embolism | Outcome | Details | |
ACRAD41 | Use of Quantitative Criteria for Oncologic FDG PET Imaging | Outcome | Details | |
HM7 | Functional Status Change for Patients with Vestibular Dysfunction | Outcome | Details | |
MSK1 | Patients Suffering From a Neck Injury who Improve Physical Function | Outcome | Details | |
MSK10 | Patients Suffering From a Knee Injury who Improve Pain | Outcome | Details | |
MSK2 | Patients Suffering From an Upper Extremity Injury who Improve Physical Function | Outcome | Details | |
MSK3 | Patients Suffering From a Back Injury who Improve Physical Function | Outcome | Details | |
MSK4 | Patients Suffering From a Lower Extremity Injury who Improve Physical Function | Outcome | Details | |
MSK5 | Patients Suffering From a Knee Injury who Improve Physical Function | Outcome | Details | |
MSK6 | Patients Suffering From a Neck Injury who Improve Pain | Outcome | Details | |
MSK7 | Patients Suffering From an Upper Extremity Injury who Improve Pain | Outcome | Details | |
MSK8 | Patients Suffering From a Back Injury who Improve Pain | Outcome | Details | |
MSK9 | Patients Suffering From a Lower Extremity Injury who Improve Pain | Outcome | Details | |
PIMSH13 | Oncology: Mutation Testing for Stage IV Lung Cancer Completed Prior to the Start of Targeted Therapy | Outcome | Details | |
PIMSH17 | Oncology: Utilization of Prophylactic GCSF for Cancer Patients Receiving Low-Risk Chemotherapy (inverse measure) | Efficiency | Details |